| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Revenue | $5.67B | +0.6% |
| Cost of Revenue | $3.24B | +1.2% |
| R&D Expense | $292.6M | -17.9% |
| SG&A Expense | $902.6M | -25.3% |
| Operating Income | $989.1M | -4.4% |
| Interest Expense | $57.9M | -25.1% |
| Pre-tax Income | $937.9M | -2.2% |
| Income Tax | $117.2M | +62.1% |
| Net Income | $819.2M |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $649.8M | +0.2% |
| Accounts Receivable | $901.1M | +0.2% |
| Inventory | $914.4M | -0.4% |
| Current Assets | $2.94B | -1.2% |
| Total Assets | $14.20B | -2.3% |
| Current Liabilities | $1.26B | -28.6% |
| Long-term Debt | $2.65B | -18.4% |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.19B | +42.6% |
| Capital Expenditures | $83.7M | -27.2% |
| Investing Cash Flow | -$207.2M | -8.9% |
| Financing Cash Flow | -$945.8M | -45.2% |
| Free Cash Flow | $1.11B | +53.7% |
| -7.5% |
| EPS (Basic) | $17.43 | -7.3% |
| EPS (Diluted) | $17.21 | -6.9% |
| Total Liabilities |
| $4.65B |
| -12.4% |
| Stockholders' Equity | $9.55B | +3.6% |